Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03980509 · ClinicalTrials.gov registry record · Phase 1
A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT03980509 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 22 participants.
The verdict
NCT03980509, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether oral administration of curcumin causes biological changes in primary tumors of breast cancer patients.
Interventions
- DRUG Curcumin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-01-29 |
| Est. Completion | 2023-03-24 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03980509
The ClinicalTrials.gov registry entry for NCT03980509 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Curcumin is the first listed.
NCT03980509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03980509 about?
NCT03980509 is a clinical study titled "A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors". The purpose of this study is to determine whether oral administration of curcumin causes biological changes in primary tumors of breast cancer patients.
What is the current status of trial NCT03980509?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2020-01-29. Estimated completion is 2023-03-24.
What interventions are being tested in trial NCT03980509?
The interventions under investigation include: Curcumin (DRUG).
Who is sponsoring clinical trial NCT03980509?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.